Most people who stop GLP-1 drugs like Ozempic eventually return
AI Summary
A recent study highlights that while many individuals prescribed GLP-1 drugs for type 2 diabetes eventually stop taking them, a significant portion returns to using these medications. Side effects are a primary reason for discontinuation, though newer drugs seem to improve adherence. This trend is crucial because it underscores the ongoing challenges in managing type 2 diabetes, emphasizing the need for better patient education and support to maintain long-term treatment efficacy.
Original Source
Read the full article at Sciencedaily →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.